Your browser doesn't support javascript.
loading
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma.
McDonald, Michelle M; Reagan, Michaela R; Youlten, Scott E; Mohanty, Sindhu T; Seckinger, Anja; Terry, Rachael L; Pettitt, Jessica A; Simic, Marija K; Cheng, Tegan L; Morse, Alyson; Le, Lawrence M T; Abi-Hanna, David; Kramer, Ina; Falank, Carolyne; Fairfield, Heather; Ghobrial, Irene M; Baldock, Paul A; Little, David G; Kneissel, Michaela; Vanderkerken, Karin; Bassett, J H Duncan; Williams, Graham R; Oyajobi, Babatunde O; Hose, Dirk; Phan, Tri G; Croucher, Peter I.
Afiliação
  • McDonald MM; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Reagan MR; St. Vincent's School of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Youlten SE; Dana-Farber Cancer Institute, Boston, MA.
  • Mohanty ST; Maine Medical Center Research Institute, Scarborough, ME.
  • Seckinger A; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Terry RL; St. Vincent's School of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Pettitt JA; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Simic MK; UniversitätsKlinikum Heidelberg, Medizinische Klinik V, Labors für Myelomforschung, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany.
  • Cheng TL; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Morse A; St. Vincent's School of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Le LMT; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Abi-Hanna D; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Kramer I; Centre for Children's Bone and Musculoskeletal Health, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Falank C; Centre for Children's Bone and Musculoskeletal Health, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Fairfield H; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Ghobrial IM; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Baldock PA; St. Vincent's School of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Little DG; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Kneissel M; Maine Medical Center Research Institute, Scarborough, ME.
  • Vanderkerken K; Maine Medical Center Research Institute, Scarborough, ME.
  • Bassett JHD; Dana-Farber Cancer Institute, Boston, MA.
  • Williams GR; The Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Oyajobi BO; St. Vincent's School of Medicine, University of New South Wales, Sydney, NSW, Australia.
  • Hose D; Centre for Children's Bone and Musculoskeletal Health, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Phan TG; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Croucher PI; Faculty of Medicine, Department of Hematology and Immunology, Frei University, Brussels, Belgium.
Blood ; 129(26): 3452-3464, 2017 06 29.
Article em En | MEDLINE | ID: mdl-28515094

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteócitos / Osteogênese / Densidade Óssea / Proteínas Morfogenéticas Ósseas / Fraturas Ósseas Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteócitos / Osteogênese / Densidade Óssea / Proteínas Morfogenéticas Ósseas / Fraturas Ósseas Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article